Literature DB >> 23737314

Predictive value of having positive family history of cardiovascular disorders, diabetes mellitus, dyslipidemia, and hypertension in non-alcoholic fatty liver disease patients.

Mohammad Ebrahim Ghamar-Chehreh1, Hossein Khedmat, Mohsen Amini, Saeed Taheri.   

Abstract

In the present study, we examined the relationship between family history of cardiovascular diseases (CVD), dyslipidemia, hypertension, and diabetes with laboratorial abnormalities and syndromes in Iranian patients with non-alcoholic fatty liver disease (NAFLD). A total of 332 NAFLD patients from our outpatient clinic were consecutively entered into analysis. Exclusion criteria were having diabetes mellitus and fasting blood glucose over 126, active hepatitis B virus infection, having HCV positive serology, and to be under corticosteroid therapy. Family history of CVD, diabetes, dyslipidemia, and hypertension were taken from patients and related to the study variables. Family history of cardiovascular diseases (CVD) was associated with low HDL levels (P=0.05). Patients with positive family history of diabetes mellitus were significantly more likely to have AST/ALT levels proportion of higher than one (P=0.044). Family history of dyslipidemia was a predictor for hypertriglyceridemia (P=0.02), higher prothrombin time levels (P=0.013), lower albumin (P=0.024) and T4 (P=0.043) levels. Family history of hypertension was associated with dysglycemia/diabetes (P=0.038), high ALT (P=0.008), and low TIBC (P=0.007) and albumin levels (P=0.001). Family history for CVD, diabetes, dyslipidemia, and hypertension were of clinical importance in the Iranian patients with NAFLD. We therefore recommend that physicians should precisely get family history of main disorders in all NAFLD patients; and to pay more attention to those having the mentioned family histories. Further studies with larger patient population and prospective approach are needed for confirming our findings.

Entities:  

Mesh:

Year:  2013        PMID: 23737314

Source DB:  PubMed          Journal:  Acta Med Iran        ISSN: 0044-6025


  6 in total

1.  Relation of Dietary Patterns and Nutritional Profile to Hepatic Fibrosis in a Sample of Lebanese Non-Alcoholic Fatty Liver Disease Patients.

Authors:  Nicole Fakhoury Sayegh; Gessica N H A Heraoui; Hassan Younes; Lea Nicole Sayegh; Christa Boulos; Raymond Sayegh
Journal:  Nutrients       Date:  2022-06-20       Impact factor: 6.706

2.  Nutritional Profile and Dietary Patterns of Lebanese Non-Alcoholic Fatty Liver Disease Patients: A Case-Control Study.

Authors:  Nicole Fakhoury-Sayegh; Hassan Younes; Gessica N H A Heraoui; Raymond Sayegh
Journal:  Nutrients       Date:  2017-11-14       Impact factor: 5.717

3.  Elevated Alanine Aminotransferase in Early Pregnancy and Subsequent Development of Gestational Diabetes and Preeclampsia.

Authors:  Seung Mi Lee; Joong Shin Park; You Jung Han; Won Kim; Seung Hyun Bang; Byoung Jae Kim; Chan Wook Park; Moon Young Kim
Journal:  J Korean Med Sci       Date:  2020-07-06       Impact factor: 2.153

4.  Increased urinary sodium excretion is associated with systolic blood pressure in first degree relatives of hypertensive patients in Ibadan, Southwestern Nigeria.

Authors:  Samuel Ajayi; Adewole Adebiyi; Solomon Kadiri
Journal:  Pan Afr Med J       Date:  2018-11-09

5.  Height predict incident non-alcoholic fatty liver disease among general adult population in Tianjin, China, independent of body mass index, waist circumference, waist-to-height ratio, and metabolic syndrome.

Authors:  Shubham Kumari; Xuena Wang; Yunyun Liu; Yeqing Gu; Yuhan Huang; Qing Zhang; Li Liu; Ge Meng; Hongmei Wu; Shaomei Sun; Xing Wang; Ming Zhou; Qiyu Jia; Guolin Wang; Kun Song; Kaijun Niu
Journal:  BMC Public Health       Date:  2020-03-24       Impact factor: 3.295

6.  The value of neck circumference (NC) as a predictor of non-alcoholic fatty liver disease (NAFLD).

Authors:  Yanyan Hu; Jinbo Chen; Lu Yang; Pin Chen; Juhong Li; Lin Chen; Jin Chen; Xiangqin Huang; Yaping Zhang; Shizhong Bu; Qin Huang
Journal:  J Clin Transl Endocrinol       Date:  2014-07-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.